Guy Young/LinkedIn;
Mark T. Reding/emedevents.com/
Mar 12, 2026, 11:50
Guy Young: Clinical Conversations on Gene Therapy Progress in Hemophilia B at THSNA 2026
Guy Young, Director of the Hemostasis and Thrombosis Center at Children’s Hospital Los Angeles, shared a post on LinkedIn:
“I’m looking forward to speaking at THSNA 2026 on Driving Innovation Forward in Hemophilia B With Gene Therapy: Clinical Conversations on Progress and Guidance on Practical Delivery.
Join Mark T. Reding, MD and I as we discuss:
- Clarifying the role of gene therapy in hemophilia B within an evolving treatment landscape
- Improving patient selection and counseling in real-world practice
- Operationalizing delivery – from referral coordination to infusion management, monitoring, and long-term follow-up across care settings
This symposium will take place live in person on March 21 at 6:45 AM PDT at the Oregon Convention Center in Portland during the THSNA 2026 Annual Meeting, with a live virtual program to follow on March 30 at 7:00 PM EDT.
Other posts featuring Guy Young on Hemostasis Today.
-
May 1, 2026, 08:04Erwin Loh: Your Morning Coffee May Help Protect Your Body Against Aging
-
May 1, 2026, 07:50Wolfgang Miesbach: Practice-Changing Insights on the Efficacy and Safety of Platelet Transfusions at the EHA-SWG
-
May 1, 2026, 07:27What Does “Successful Ageing” Really Mean for People Living with Haemophilia Today? – EAHAD
-
Apr 30, 2026, 18:19Deva Nanda TK: A Practical Overview of Dural Sinuses and The Venous Drainage of the Brain
-
Apr 30, 2026, 18:08Amrit Kaur Kaler: The Hidden Genetic Drivers of Thrombosis
-
Apr 30, 2026, 18:06Alejandro González Veliz: The Most Dangerous Mistake After Getting a Stent
-
Apr 30, 2026, 18:03Carmen Ruiz: First Arterial Mechanical Thrombectomy in New Zealand Using the ARTIX System
-
Apr 30, 2026, 17:52Simon Senanu: von Willebrand Disease May Be Missed Despite Normal Tests
-
Apr 30, 2026, 17:20José Antonio García Erce: Why Healthy Older Adults Should Keep Donating Blood?